NCT02408432View on ClinicalTrials.gov

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 11, 2016

Primary Completion Date

December 8, 2021

Study Completion Date

December 8, 2021

Conditions
CardiomyopathyHeart Failure
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Standard of Care

Undergo mesenchymal stem cell infusion

DRUG

Mesenchymal Stem Cell Transplantation

Undergo mesenchymal stem cell infusion

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02408432 - Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines | Biotech Hunter | Biotech Hunter